Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBLITUXIMAB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where UBLITUXIMAB was used for B-cell lymphoma.

Most Reported Side Effects for UBLITUXIMAB

Side Effect Reports % Deaths Hosp.
Infusion related reaction 538 34.0% 0 21
Fatigue 110 7.0% 1 9
Headache 55 3.5% 1 5
Inappropriate schedule of product administration 53 3.4% 1 0
Malaise 49 3.1% 0 3
Multiple sclerosis relapse 48 3.0% 1 18
Asthenia 45 2.8% 0 7
Pain 45 2.8% 0 5
Illness 43 2.7% 0 4
Urinary tract infection 42 2.7% 2 13
Covid-19 39 2.5% 1 11
Gait disturbance 37 2.3% 0 5
Nasopharyngitis 37 2.3% 1 3
Nausea 37 2.3% 1 4
Pain in extremity 37 2.3% 1 7

Other Indications for UBLITUXIMAB

Multiple sclerosis (1,455) Chronic lymphocytic leukaemia (62) Non-hodgkin's lymphoma (17) Product used for unknown indication (12) Relapsing multiple sclerosis (11) Follicular lymphoma (5)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

UBLITUXIMAB Full Profile All B-cell lymphoma Drugs UBLITUXIMAB Demographics UBLITUXIMAB Timeline